Trials / Completed
CompletedNCT00356798
Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects
The Phase-I Clinical Trial Protocol for the Pandemic Inactivated Influenza Vaccine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 120 (planned)
- Sponsor
- Sinovac Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Based on pre-clinical trial data and principle of GCP, the objective of phase I clinical trial is to evaluate safety and immunogenicity of Pan-flu vaccine, an inactivated whole virion H5N1 vaccine with aluminium hydroxide adjuvant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | an inactivated whole virion H5N1 vaccine, adjuvanted |
Timeline
- Start date
- 2005-12-01
- Completion
- 2006-04-01
- First posted
- 2006-07-26
- Last updated
- 2007-11-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00356798. Inclusion in this directory is not an endorsement.